JP2013514811A5 - - Google Patents

Download PDF

Info

Publication number
JP2013514811A5
JP2013514811A5 JP2012546131A JP2012546131A JP2013514811A5 JP 2013514811 A5 JP2013514811 A5 JP 2013514811A5 JP 2012546131 A JP2012546131 A JP 2012546131A JP 2012546131 A JP2012546131 A JP 2012546131A JP 2013514811 A5 JP2013514811 A5 JP 2013514811A5
Authority
JP
Japan
Prior art keywords
bmp
variant
cell
item
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012546131A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013514811A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/061437 external-priority patent/WO2011087768A1/en
Publication of JP2013514811A publication Critical patent/JP2013514811A/ja
Publication of JP2013514811A5 publication Critical patent/JP2013514811A5/ja
Pending legal-status Critical Current

Links

JP2012546131A 2009-12-22 2010-12-21 免疫原性が抑制されたbmp−7変異体 Pending JP2013514811A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28922009P 2009-12-22 2009-12-22
US61/289,220 2009-12-22
PCT/US2010/061437 WO2011087768A1 (en) 2009-12-22 2010-12-21 Bmp-7 variants with reduced immunogenicity

Publications (2)

Publication Number Publication Date
JP2013514811A JP2013514811A (ja) 2013-05-02
JP2013514811A5 true JP2013514811A5 (cg-RX-API-DMAC7.html) 2014-01-09

Family

ID=43735952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546131A Pending JP2013514811A (ja) 2009-12-22 2010-12-21 免疫原性が抑制されたbmp−7変異体

Country Status (7)

Country Link
US (1) US20130190236A1 (cg-RX-API-DMAC7.html)
EP (1) EP2516456A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013514811A (cg-RX-API-DMAC7.html)
CN (1) CN102822197A (cg-RX-API-DMAC7.html)
AU (1) AU2010341565A1 (cg-RX-API-DMAC7.html)
CA (1) CA2785038A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011087768A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3197474B1 (en) * 2014-09-26 2023-06-07 Rajendra Sahai Bhatnagar Inhibitors of nf kappa-b activity for treatment of diseases and disorders
KR20170100634A (ko) 2014-12-29 2017-09-04 바이오벤터스 엘엘씨 골 복구에서의 골유도 분자의 전달 향상을 위한 시스템 및 방법
WO2019148140A2 (en) * 2018-01-26 2019-08-01 Wu Joseph C Implantable biomaterials that enhance stem cell survival and function

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US6919308B2 (en) 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
AU666291B2 (en) 1990-06-15 1996-02-08 Carnegie Institution Of Washington Gdf-1
US6506729B1 (en) 1991-03-11 2003-01-14 Curis, Inc. Methods and compositions for the treatment and prevention of Parkinson's disease
US5674844A (en) 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5656593A (en) 1991-03-11 1997-08-12 Creative Biomolecules, Inc. Morphogen induced periodontal tissue regeneration
US5849686A (en) 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US6949505B1 (en) 1991-03-11 2005-09-27 Curis, Inc. Morphogen-induced dendritic growth
US6800603B2 (en) 1991-03-11 2004-10-05 Curis, Inc. Morphogen-induced neural cell adhesion
US6287816B1 (en) 1991-06-25 2001-09-11 Genetics Institute, Inc. BMP-9 compositions
KR100259827B1 (ko) 1991-11-04 2000-06-15 브루스 엠. 에이센, 토마스 제이 데스로저 재조합 골형태 형성 단백질 헤테로다이머, 그 조성물 및 사용방법
CA2129820C (en) 1992-02-12 2003-06-17 Helge Neidhardt Dna sequences encoding novel growth/differentiation factors
WO1994010203A2 (en) 1992-11-03 1994-05-11 Creative Biomolecules, Inc. Op-3-induced morphogenesis
EP0690871A4 (en) 1993-01-12 1999-10-20 Univ Johns Hopkins Med GROWTH DIFFERENTIATION FACTOR-5
WO1994015966A1 (en) 1993-01-12 1994-07-21 Johns Hopkins University School Of Medicine Growth differentiation factor-9
CA2157577C (en) 1993-03-19 2009-11-17 Se-Jin Lee Growth differentiation factor-8
ATE265529T1 (de) 1993-05-12 2004-05-15 Inst Genetics Llc Bmp-10 zusammensetzungen
EP0698094B1 (en) 1993-05-12 2004-02-04 Genetics Institute, LLC Bmp-11 compositions
JPH09503903A (ja) 1993-07-09 1997-04-22 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 増殖分化因子−6
EP0725796A4 (en) 1993-10-08 1999-12-01 Univ Johns Hopkins Growth differentiation factor-10
DE4334646C1 (de) 1993-10-12 1994-09-29 Quinting Friedhelm Durchsichtige Analog-Zeituhr
JP3300500B2 (ja) 1993-10-12 2002-07-08 新日本製鐵株式会社 疲労強度、降伏強度および被削性に優れる熱間鍛造用鋼の製造方法
US5399677A (en) 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
EP0733109B9 (en) 1993-12-07 2006-07-05 Genetics Institute, LLC Bmp-12, bmp-13 and tendon-inducing compositions thereof
IL114397A0 (en) 1994-07-01 1995-10-31 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF-beta-family
DE69534468T2 (de) 1994-07-08 2006-07-13 The Johns Hopkins University School Of Medicine Wachstums-differenzierungsfaktor-11
WO1996014335A1 (en) 1994-11-07 1996-05-17 The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health And Human Services Cartilage-derived morphogenetic proteins
US5635372A (en) 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
ATE493141T1 (de) 1996-03-22 2011-01-15 Stryker Corp Verfahren zur verbesserten funktionellen erholung der motorischen koordiination, der sprache oder der sinneswahrnehmung nach trauma oder ischämie des zns
US6498142B1 (en) 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
US6958149B2 (en) 1998-10-06 2005-10-25 Stryker Corporation Repair of larynx, trachea, and other fibrocartilaginous tissues
US6677432B1 (en) 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins
JP3762222B2 (ja) 1998-10-07 2006-04-05 ストライカー・コーポレーション 改変型TGF−βスーパーファミリータンパク質
US6846906B1 (en) 1998-10-07 2005-01-25 Stryker Corporation Modified proteins of the TGF-β superfamily, including morphogenic proteins
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
US8154581B2 (en) 2002-10-15 2012-04-10 Revolutionary Concepts, Inc. Audio-video communication system for receiving person at entrance
WO2005044838A2 (en) * 2003-11-03 2005-05-19 Genencor International, Inc. Cd4+ epitopes of bone morphogenetic proteins
CA2561809A1 (en) * 2004-03-31 2005-10-20 Xencor, Inc. Bmp-7 variants with improved properties
US20090042780A1 (en) 2004-05-20 2009-02-12 Acceleron Pharma Inc Modified TGF-Beta Superfamily Polypeptides and Related Methods
CA2567405A1 (en) 2004-05-25 2005-12-08 Stryker Corporation Use of morphogenic proteins for treating cartilage defects
ATE543833T1 (de) * 2005-12-22 2012-02-15 Janssen Biotech Inc Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
US7659250B2 (en) * 2005-12-22 2010-02-09 Centocor, Inc. BMP-7 variant compositions, methods and uses
WO2008051526A2 (en) * 2006-10-23 2008-05-02 Stryker Corporation Bone morphogenetic proteins
EP2222696A1 (en) * 2007-12-21 2010-09-01 Stryker Corporation Bmp mutants with decreased susceptibility to noggin
WO2010117047A1 (ja) 2009-04-10 2010-10-14 株式会社ニコン 光学材料、光学素子、及びその製造方法
JP2011211450A (ja) 2010-03-30 2011-10-20 Victor Co Of Japan Ltd 立体映像表示装置、立体映像撮像装置および立体映像表示方法
US9507084B2 (en) 2010-12-03 2016-11-29 Ofs Fitel, Llc Single-mode, bend-compensated, large-mode-area optical fibers designed to accomodate simplified fabrication and tighter bends
US8886307B2 (en) 2012-01-30 2014-11-11 Medtronic, Inc. Adaptive cardiac resynchronization therapy
KR101851912B1 (ko) 2012-06-07 2018-04-24 아사히 가세이 일렉트로닉스 가부시끼가이샤 위치 검출 장치
US9298469B2 (en) 2012-06-15 2016-03-29 International Business Machines Corporation Management of multiple nested transactions
US9405290B1 (en) 2013-01-17 2016-08-02 Kla-Tencor Corporation Model for optical dispersion of high-K dielectrics including defects
JP6154215B2 (ja) 2013-06-28 2017-06-28 株式会社日立国際電気 半導体装置の製造方法、基板処理装置およびプログラム
US9170581B2 (en) 2013-09-30 2015-10-27 Crown Equipment Limited Industrial vehicles with overhead light based localization
JP6541301B2 (ja) 2014-03-28 2019-07-10 キヤノン株式会社 ロボット装置、ロボット装置の制御方法、ロボット制御プログラム、及び記録媒体
US9411440B2 (en) 2014-08-22 2016-08-09 Qualcomm Incorporated Digital ultrasonic emitting base station
US9407762B2 (en) 2014-10-10 2016-08-02 Bank Of America Corporation Providing enhanced user authentication functionalities
US9412814B2 (en) 2014-12-24 2016-08-09 Taiwan Semiconductor Manufacturing Co., Ltd. Structure and formation method of FinFET device
US9400685B1 (en) 2015-01-30 2016-07-26 Huawei Technologies Co., Ltd. Dividing, scheduling, and parallel processing compiled sub-tasks on an asynchronous multi-core processor

Similar Documents

Publication Publication Date Title
EA201300054A1 (ru) Полипептид, обладающий активностью бета-глюкозидазы, и его применение
EA200800368A1 (ru) Гликозилированный il-7, получение и применение
SA522433360B1 (ar) L-أَسْباراجيناز مُعدل
WO2006119987A3 (en) Recombinant n-glycosylated proteins from procaryotic cells
MX2009008118A (es) Polipeptido e2 del virus del papiloma usado para vacunacion.
JP2011528332A5 (cg-RX-API-DMAC7.html)
JP2010519293A5 (cg-RX-API-DMAC7.html)
JP2018537089A5 (cg-RX-API-DMAC7.html)
JP2009508471A5 (cg-RX-API-DMAC7.html)
JP2015504675A5 (cg-RX-API-DMAC7.html)
NZ602693A (en) Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
JPWO2019156137A5 (cg-RX-API-DMAC7.html)
JP2014529399A5 (cg-RX-API-DMAC7.html)
MY167485A (en) Recombinant human interferon-like proteins
JP2017503505A5 (cg-RX-API-DMAC7.html)
CN101514231A (zh) 靶向性抗血栓形成的融合蛋白及其制备方法和应用
CN101463089B (zh) 人血清白蛋白-干扰素融合蛋白及其编码基因与应用
RU2007103735A (ru) Детоксифизим с активностью преобразования афлатоксина и ген, кодирующий детоксифизим
RU2010125695A (ru) Гены, кодирующие главный капсидный белок l1 вируса папилломы человека, и их применение
EP4282490A3 (en) Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy
JP2009507474A5 (cg-RX-API-DMAC7.html)
JP2014515595A5 (cg-RX-API-DMAC7.html)
CA2795308A1 (en) Parapoxvirus expressing the vp60 major capsid protein of the rabbit haemorrhagic disease virus
JP2014512369A5 (cg-RX-API-DMAC7.html)
CN103882028B (zh) 重组人碱性成纤维细胞生长因子蛋白的制备方法